Enantiomerically Pure Quinoline‐Based κ‐Opioid Receptor Agonists: Chemoenzymatic Synthesis and Pharmacological Evaluation
暂无分享,去创建一个
T. Che | B. Wünsch | T. Schmidt | K. Loser | D. Schepmann | F. Bernal | B. Martin
[1] Martina Kunkl,et al. T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis , 2020, Cells.
[2] M. Sugaya. The Role of Th17-Related Cytokines in Atopic Dermatitis , 2020, International journal of molecular sciences.
[3] Sunmo Yang,et al. Understanding the immunopathogenesis of autoimmune diseases by animal studies using gene therapy: A comprehensive review. , 2020, Autoimmunity reviews.
[4] G. Melino,et al. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo , 2020, Cell cycle.
[5] Ao Wang,et al. Dendritic cells: The driver of psoriasis , 2019, The Journal of dermatology.
[6] Pei Yang,et al. Th17 cell pathogenicity and plasticity in rheumatoid arthritis , 2019, Journal of leukocyte biology.
[7] E. Shevach,et al. Helios: still behind the clouds , 2019, Immunology.
[8] Adriana Rendon,et al. Psoriasis Pathogenesis and Treatment , 2019, International journal of molecular sciences.
[9] T. Che,et al. Development of Novel Quinoxaline-Based κ-Opioid Receptor Agonists for the Treatment of Neuroinflammation. , 2018, Journal of medicinal chemistry.
[10] C. Daniliuc,et al. Stereoselective synthesis of conformationally restricted KOR agonists based on the 2,5-diazabicyclo[2.2.2]octane scaffold. , 2017, Organic & biomolecular chemistry.
[11] R. Stevens,et al. Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor. , 2017, Journal of medicinal chemistry.
[12] Changsheng Du,et al. Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination , 2016, Nature Communications.
[13] R. Fröhlich,et al. Conformationally restricted κ-opioid receptor agonists: Synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinoxalines. , 2015, Bioorganic & medicinal chemistry letters.
[14] Maria F. Sassano,et al. PRESTO-TANGO: an open-source resource for interrogation of the druggable human GPCR-ome , 2015, Nature Structural &Molecular Biology.
[15] B. Wünsch,et al. Synthesis and σ receptor affinity of regioisomeric spirocyclic furopyridines. , 2014, European journal of medicinal chemistry.
[16] H. Galla,et al. Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists. , 2014, Journal of medicinal chemistry.
[17] R. Fröhlich,et al. Synthesis and pharmacological evaluation of like- and unlike-configured tetrahydro-2-benzazepines with the α-substituted benzyl moiety in the 5-position. , 2014, Organic & biomolecular chemistry.
[18] R. Bodnar. Endogenous opiates and behavior: 2012 , 2013, Peptides.
[19] J. Kraus,et al. Inhibition of NF-κB by Opioids in T Cells , 2013, The Journal of Immunology.
[20] B. Wünsch,et al. Improvement of σ1 receptor affinity by late-stage C-H-bond arylation of spirocyclic lactones. , 2013, Bioorganic & medicinal chemistry.
[21] Weiwei Jin,et al. Brønsted acid activation strategy in transition-metal catalyzed asymmetric hydrogenation of N-unprotected imines, enamines, and N-heteroaromatic compounds. , 2012, Angewandte Chemie.
[22] Zhengkun Yu,et al. Brønsted‐Säure‐Aktivierung bei der übergangsmetallkatalysierten asymmetrischen Hydrierung N‐ungeschützter Imine, Enamine und N‐Heteroarene , 2012 .
[23] R. Stevens,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[24] C. Stein,et al. Modulation of Peripheral Sensory Neurons by the Immune System: Implications for Pain Therapy , 2011, Pharmacological Reviews.
[25] B. Wünsch,et al. Conformationally constrained kappa receptor agonists: stereoselective synthesis and pharmacological evaluation of 6,8-diazabicyclo[3.2.2]nonane derivatives. , 2010, Journal of medicinal chemistry.
[26] R. Fröhlich,et al. Stereoselective synthesis and structure-affinity relationships of bicyclic kappa receptor agonists. , 2010, Organic & biomolecular chemistry.
[27] T. Vanderah. Delta and Kappa Opioid Receptors as Suitable Drug Targets for Pain , 2010, The Clinical journal of pain.
[28] H. Mochizuki,et al. Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients. , 2009, Drugs of today.
[29] P. Stephens,et al. ECD cotton effect approximated by the Gaussian curve and other methods. , 2009, Chirality.
[30] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[31] Bryan L. Roth,et al. Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Uenishi,et al. Synthesis of Enantiomerically Pure 8-Substituted 5,6,7,8-Tetrahydroquinolines , 2002 .
[33] M. Kozlowski,et al. ChemInform Abstract: Synthesis and Conformational Properties of N-Monoalkyl 1,5-Diaza-cis-decalins. , 2001 .
[34] J. Bidlack. Detection and Function of Opioid Receptors on Cells from the Immune System , 2000, Clinical Diagnostic Laboratory Immunology.
[35] S. Salvadori,et al. Pharmacology of nociceptin and its receptor: a novel therapeutic target , 2000, British journal of pharmacology.
[36] H. Nagase,et al. Discovery of a structurally novel opioid kappa-agonist derived from 4,5-epoxymorphinan. , 1998, Chemical & pharmaceutical bulletin.
[37] P B Bradley,et al. International Union of Pharmacology. XII. Classification of opioid receptors. , 1996, Pharmacological reviews.
[38] R. Mach,et al. Ibogaine possesses a selective affinity for σ2 receptors , 1995 .
[39] D. DeHaven-Hudkins,et al. Characterization of the binding of [3H](+)-pentazocine to σ recognition sites in guinea pig brain , 1992 .
[40] W. Bowen,et al. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands. , 1989, Journal of medicinal chemistry.
[41] P. von Voigtlander,et al. Benzeneacetamide amines: structurally novel non-m mu opioids. , 1982, Journal of medicinal chemistry.
[42] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[43] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[44] V. Boekelheide,et al. Rearrangements of N-Oxides. A Novel Synthesis of Pyridyl Carbinols and Aldehydes , 1954 .
[45] M. Waldhoer,et al. Opioid receptors. , 2004, Annual review of biochemistry.
[46] H. Buschmann,et al. Gemischte opioide Agonisten/Antagonisten und partielle Agonisten: Zwei komplexe Wirkprinzipien in einer Struktur , 2002 .
[47] C. Stoscheck,et al. Quantitation of protein. , 1990, Methods in enzymology.